Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Florida for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Florida only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Florida (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

John Myers (NPI 1881661585)

Field	Value
Entity Type	Individual
Organization	John Myers
Address	5150 N Davis Hwy
City	Pensacola
State	FL
ZIP	32503
Taxonomy	Retina Specialist (Ophthalmology) Physician
NPI Enumerated	March 2, 2006

Payer Source	Total Paid
Medicare	$5.4M
Medicaid	$0

Key Findings

This provider’s Medicare activity is dominated by intravitreal medication and injection procedures consistent with a retina-specialist practice: J2778 reports 12.8K claims and $2.3M revenue (42.8% of total Medicare revenue), J0178 reports 2.4K claims and $1.6M revenue (30.1%), and the intravitreal injection procedure 67028 reports 3.8K claims and $349.7K revenue (6.5%). High volumes in related codes for retinal imaging and follow-up—92134 (4.8K claims, $138K) and 92014 (3.5K claims, $304.3K)—further support a service model built around frequent injections, imaging, and longitudinal retina care.

Revenue is highly concentrated: the precomputed top three Medicare codes (J2778, J0178, 67028) account for 79.4% of this provider’s total Medicare revenue, and total Medicare revenue on file is $5.4M. That concentration indicates financial dependence on a narrow set of drug and injection services rather than a broader mix of high-revenue surgical or multispecialty services.

Payer mix is effectively single-payer on file: the record shows Total Medicare revenue of $5.4M and no Medicaid billing on file. The absence of Medicaid activity means any contracting, utilization management, or risk for this provider will largely be driven by Medicare exposure rather than state Medicaid programs.

The provider is a national-volume outlier on several key codes, indicating a dominant position for specific services: J2778 ranks #4 of 1208 providers nationally (100th percentile; extreme outlier) and 67028 ranks #36 of 4255 (99th percentile; extreme outlier), while 92014 ranks #29 of 35415 (100th percentile; extreme outlier). These rankings signal that this clinician is operating at substantially higher volumes for ranibizumab injections, intravitreal injection procedures, and comprehensive ophthalmological follow-ups than typical peers.

Other intravitreal agents and compound drug use are present but at more typical volumes: J0178 (aflibercept) ranks #370 of 3204 (88th percentile; typical, unremarkable volume), J2777 ranks #1057 of 2039 (48th percentile; typical, unremarkable volume), and J2781 ranks #122 of 490 (75th percentile; typical, unremarkable volume). This pattern suggests diversified use of multiple anti-VEGF and investigational agents, but only J2778 reaches extreme national volume.

Visit- and imaging-related codes also show unusually high professional throughput: 99213 reports 1.1K claims and $64.5K revenue and ranks #4742 of 457151 providers (99th percentile; extreme outlier), and 99203 reports 261 claims and $19.3K revenue and ranks #1893 of 161519 (99th percentile; extreme outlier). Combined with high counts for 92134 and 92014, this indicates an operational workflow with substantial clinic visit volume to support the injection schedule and monitoring needs of retinal disease.

Tenure and practice stability are notable: the NPI was enumerated 2006-03-02 (~20 years ago), indicating a long-established billing history. The combination of multi-year enumeration and the high-claim counts for key injection codes (e.g., 12.8K claims for J2778) points to a sustained, high-volume retina practice rather than a recent or transient billing pattern.

For payer and contracting strategy, the dominant revenue drivers to target are drug reimbursement and injection-related procedure codes—specifically J2778 ($2.3M) and J0178 ($1.6M) together represent the majority of Medicare revenue—and utilization management or drug-specific agreements would likely have the largest financial impact. Given no Medicaid billing on file, Medicaid-specific network or payment strategies are unlikely to affect this provider unless future enrollment or billing patterns change.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

23 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J2778	Injection, ranibizumab, 0.1 mg	12,790	$180	$2.3M
J0178	Injection, aflibercept, 1 mg	2,360	$690	$1.6M
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	3,840	$90	$349.7K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	3,540	$90	$304.3K
J2777	Injection, faricimab‑svoa, 0.1 mg	9,360	$30	$271.4K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	4,760	$30	$138K
J2781	Injection, pegcetacoplan, intravitreal, 1 mg	990	$120	$118.8K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	1,130	$60	$64.5K
J3490	Unclassified drugs	40	$1,740	$62.7K
67042	In this procedure, the provider removes vitreous humor, the gelatinous material that gives shape to the eye, using a mechanical cutting tool. He removes the internal limiting membrane of the retina…	40	$880	$36.8K

Showing 1–10 of 23

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 23 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Florida Distribution

John Myers — 6 of 23 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Florida

Full comparison — all codes billed, vs. state median

23 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	34	250	800	$690	$817.6K
J2777	112	170	12,810	$30	$549.2K
J2778	1	110	660	$180	$234.1K
J2781	12	50	500	$120	$102K
67028	9	300	710	$90	$91.1K
J3490	138	180	70	$280	$87.5K
67042	14	80	20	$1,180	$36.5K
67036	47	70	20	$1,050	$31.4K
92014	3	2,180	160	$80	$28.5K
92012	566	1,170	110	$60	$16.7K

Showing 1–10 of 23

Related Providers

Other providers that share a Tax Identification Number (TIN) with John Myers, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Sunil Gupta	FL	Retina Specialist (Ophthalmology) Physician	$11.4M	$36.1K
Ryan Tarantola	FL	Retina Specialist (Ophthalmology) Physician	$5.5M	$0
Ahmet Ozkok	FL	Ophthalmology Physician	$2.1M	$193.6K
Magdalena Shuler	FL	Retina Specialist (Ophthalmology) Physician	$2M	$0
Sean Allison	MS	Retina Specialist (Ophthalmology) Physician	$1.7M	$33.4K
Anne Baranano	MS	Retina Specialist (Ophthalmology) Physician	$1.7M	$530
George Peters	MA	Ophthalmology Physician	$1.6M	$0
Shalesh Kaushal	FL	Ophthalmology Physician	$546.1K	$2.4K

Nearby Providers

Other providers in the same ZIP code as John Myers, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Baptist Health Care, Inc	FL	General Acute Care Hospital	$0	$18.4M
Interventional Therapeutics Institute, LLC	FL	Ambulatory Surgical Clinic/Center	$2.8M	$7.6K
Coyt Rountree	FL	Radiation Oncology Physician	$2.5M	$0
Rami Owera	FL	Medical Oncology Physician	$2.3M	$0
Jamal Joudeh	FL	Medical Oncology Physician	$2.1M	$0
Endoscopy Group LLC	FL	Ambulatory Surgical Clinic/Center	$1.6M	$253.9K
The Surgery Center At Woodlands, LLC	FL	Ambulatory Surgical Clinic/Center	$1.8M	$0
Shailesh Patel	FL	Medical Oncology Physician	$1.6M	$0
John Schaub	FL	Medical Oncology Physician	$1.6M	$0
Vivid Pathology PA	FL	Anatomic Pathology & Clinical Pathology Physician	$877.8K	$591K

John Myers — Billing Profile & Reimbursement Data

Sign up for John Myers — Billing Profile & Reimbursement Data policy alerts

John Myers — Billing Profile & Reimbursement Data

Sign up for John Myers — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References